Zeit | Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
08.12. | Japan GDP Data Due On Monday | 303 | AFX News | BEIJING (dpa-AFX) - Japan will on Monday release Q3 figures for gross domestic product, highlighting a light day for Asia-Pacific economic activity. GDP is seen steady from the three months... ► Artikel lesen | |
08.12. | Sanofi-Aventis Announces Positive Results For Rilzabrutinib In Phase 3 ITP Study | 797 | AFX News | PARIS (dpa-AFX) - Sanofi-Aventis Groupe announced positive results from the pivotal LUNA 3 phase 3 study of rilzabrutinib in adults with persistent or chronic immune thrombocytopenia (ITP),... ► Artikel lesen | |
08.12. | Beam Therapeutics Announces Positive Data From Phase 1/2 Trial Of BEAM-101 In Sickle Cell Disease | 519 | AFX News | WASHINGTON (dpa-AFX) - Beam Therapeutics Inc. (BEAM) announced new safety and efficacy data from its BEACON Phase 1/2 clinical trial of BEAM-101 in patients with sickle cell disease (SCD) with... ► Artikel lesen | |
08.12. | Nektar's NKTR-255 After CD19 CAR-T Therapy Enhances Complete Response In R/R Large B-Cell Lymphoma | 731 | AFX News | WASHINGTON (dpa-AFX) - Nektar Therapeutics (NKTR) announced results of its Phase 2 proof-of-concept study, which evaluated NKTR-255 as an adjuvant treatment to enhance complete response rate... ► Artikel lesen | |
08.12. | AbbVie: Epcoritamab Combo Shows High Response Rates In R/R Follicular Lymphoma Trial | 593 | AFX News | WASHINGTON (dpa-AFX) - AbbVie (ABBV) announced updated results from the Phase 1b/2 EPCORE NHL-2 trial evaluating fixed-duration investigational epcoritamab, a CD3xCD20 bispecific T-cell-engaging... ► Artikel lesen | |
08.12. | REGN: Poze-Cemdi Combo In Phase 3 Result Shows Superior Hemolysis Control In PNH Vs. Ravulizumab | 601 | AFX News | WASHINGTON (dpa-AFX) - Regeneron Pharmaceuticals Inc. (REGN) announced positive updated Phase 3 data of an exploratory cohort from the ACCESS-1 trial investigating its first-in-class pozelimab... ► Artikel lesen |
Suchbegriffe der letzen 24 h | Anzahl |
---|---|
TESLA | 391 |
NVIDIA | 368 |
LILIUM | 361 |
BAYER | 260 |
NOVO NORDISK | 257 |
EVOTEC | 214 |
BYD | 204 |
TUI | 194 |
PALANTIR TECHNOLOGIES | 187 |
VOLKSWAGEN | 180 |
D-WAVE QUANTUM | 177 |
MICROSTRATEGY | 177 |
AIXTRON SE | 111 |
NEL | 109 |
RHEINMETALL | 100 |
XIAOMI | 100 |
RWE | 99 |
SUPER MICRO COMPUTER | 98 |
BASF | 95 |
ATOS | 94 |
COMMERZBANK | 89 |
AMAZON | 85 |
NIO INC ADR | 81 |
DEUTSCHE TELEKOM | 80 |
PLUG POWER | 79 |